Joseph Jenkins
Family Medicine · Port Lavaca, TXNPI 1962655803
Payments from drug & device makers
Across 124 payments — averaging $16.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$443
- Amgen$259
- Lilly USA, LLC$224
- AstraZeneca$172
- GSK$153
- Pfizer$130
- plus $661 from 17 others
What the payments were for
- Food & beverage$2,03199%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $443 |
| Amgen | 18 | $259 |
| Lilly USA, LLC | 14 | $224 |
| AstraZeneca | 11 | $172 |
| GSK | 8 | $153 |
| Pfizer | 7 | $130 |
| Boehringer Ingelheim | 5 | $115 |
| Merck | 6 | $84 |
| Corium, LLC | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Johnson & Johnson | 4 | $54 |
| AbbVie | 3 | $46 |
| Novartis | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| Abbott | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Organon | 1 | $5 |
How this compares
$2,043 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 152 | $192,601 |
| MounjaroTirzepatide | 109 | $137,196 |
| EliquisApixaban | 147 | $113,452 |
| JanuviaSitagliptin Phosphate | 83 | $84,526 |
| TrulicityDulaglutide | 68 | $80,759 |
| JardianceEmpagliflozin | 43 | $62,255 |
| FarxigaDapagliflozin Propanediol | 59 | $58,726 |
| OtezlaApremilast | 11 | $54,283 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $42,401 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $29,640 |
| XareltoRivaroxaban | 29 | $28,670 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $25,398 |
| Tresiba Flextouch U-200Insulin Degludec | 38 | $21,650 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $18,247 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $13,136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $224 | $217,955177 claims |
| Novo NordiskOzempic | $443 | $192,601152 claims |
| PfizerEliquis | $130 | $113,452147 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere, Symbicort | $172 | $85,456113 claims |
| MerckJanuvia | $84 | $84,52683 claims |
| Boehringer IngelheimJardiance, Tradjenta | $115 | $72,21056 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $153 | $60,429105 claims |
| AmgenOtezla | $259 | $54,28311 claims |
| Johnson & JohnsonXarelto | $54 | $28,67029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Port Lavaca
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.